Validus Cellular Therapeutics
Validus Cellular Therapeutics

Market for Anti-infective cell therapies


Initial Indication

Orthopedic Infections

  • $4.5 billion US market (150,000+ annually)*
  • Europe and Asia markets to follow

Follow-on Indications

  •  Surgical site, device-associated, pneumonia, skin and soft tissue
  • Directly accessible with additional clinical studies using the same biomanufacturing protocols

*Calculation based on $30,000 treatment price of comparable cell therapies